January 12, 2022
Via: The Wall Street JournalBiopharmaceutical firm Pardes Biosciences Inc. plans to spend a large chunk of the funds it raised through a public offering late last month on a pill it is developing to treat Covid-19, including on manufacturing and hiring more clinical staff. […]
November 16, 2021
Via: The Wall Street JournalPfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. Under the licensing agreement, the United Nations-backed Medicines Patent Pool […]
July 9, 2024
June 25, 2024
Copyright © 2024. All rights reserved
